Nanoparticles as experimental brain cancer treatment. Spherical nucleic acid (SNA) nanoparticles (yellow) in laboratory (mouse) brain tissue implanted with human glioma cells, a type of brain cancer. The SNA nanoparticles are carrying a therapeutic microRNA molecule that can cross the blood-brain barrier. Cancers in the brain are especially difficult to treat because a protective blood-brain barrier blocks the entry of most drugs. Researchers are investigating the use of new nanotechnology methods to carry drugs across the barrier. This image was created in 2014, as part of research carried out at the Lurie Cancer Center at Northwestern University, USA. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Lurie Cancer Center at Northwestern University / NATIONAL CANCER INSTITUTE |
Bildgröße: | 4000 px × 4760 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |